OCON Medical's Scientific Advisory Board to Feature the Industry's Foremost Opinion Leaders
Modiin, Israel – OCON Medical has recently completed the founding of its scientific advisory board (SAB) which includes the world's leading experts and opinion leaders in the field of contraception. Following are details on each of the newly appointed members:
Prof. James Trussell - One of the world's foremost experts on family planning with particular expertise in contraceptive effectiveness and cost effectiveness. He is Professor of Economics and Public Affairs and Faculty Associate at the Office of Population Research at Princeton University as well as a visiting Professor at The Hull York Medical School with over 300 published peer reviewed papers and numerous professional affiliations.
David Hubacher, Ph.D. - A world renowned expert and key opinion leader on contraceptive methods and IUDs in particular, Dr. Hubacher serves as a senior scientist at Family Health International (FHI360). He has over 25 years research experience, authored dozens of key peer reviewed publications and speaks at conferences worldwide. He received his M.P.H. in Biostatistics and his Ph.D. in Epidemiology from UNC Chapel Hill.
Amos Ber, MD – A senior Ob/Gyn, Dr. Ber has authored over 40 peer reviewed papers and has extensive experience with hormonal IUDs, lecturing on their use globally. He is on the Board of the Israeli Society of Contraception and Sexual Health, Israeli Society of Menopause and the European society of contraception and reproductive health (ESC). Dr. Ber graduated from the Sackler faculty of medicine at the Tel Aviv University.
Valerie Tarico, Ph.D. – Dr. Tarico is deeply involved in reproductive rights and improving access to top tier contraceptives. She serves on the Board of Advocates for Youth, a D.C. based nonprofit with programs related to reproductive health and serves on Planned Parenthood’s Board of Advocates. Her articles appear on sites including the Huffington Post and the Institute for Ethics and Emerging Technologies.
"The joining of such world renowned experts to our advisory board serves as a vote of confidence in the company and its technology and further supports us in achieving our goals" said Ariel Weinstein, OCON Medical's CEO. Weinstein added that "Apart for our advisor's valuable input they are all admirably active in endorsing our innovation through their activities in promoting women's health".
The company is currently in the clinical phase of its two copper intrauterine device products and is in development of a hormonal based IUD. A therapeutic product based on its proprietary technology is also in development with additional pipeline products due to enter the development phase in the upcoming year.
OCON Medical was established in early 2011 by Dr. Ilan Baram, MD and is dedicated to women's health innovation. The company has developed a proprietary intrauterine platform which is an ideal carrier for multiple substances. The company is in the clinical phase of its initial products that are expected to reach the market in 2014 and is actively developing pipeline products for additional indications.